Multimodality imaging, including echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging, plays a complementary role in the evaluation and management of hypertrophic cardiomyopathy.
The diagnosis and management of hypertrophic cardiomyopathy (HCM) requires accurate and comprehensive imaging. Advances in imaging technology and clinical understanding have significantly enhanced the ability to characterize the phenotype, assess risk, monitor disease progression, and guide therapy. This article highlights the complementary roles of echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging in the evaluation of HCM and explores emerging research and innovation that are shaping future diagnostic and therapeutic strategies.
Peters et al. (Thu,) conducted a review in Hypertrophic cardiomyopathy. Multimodality imaging was evaluated. Multimodality imaging, including echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging, plays a complementary role in the evaluation and management of hypertrophic cardiomyopathy.